# Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue

> **NCT02985255** · PHASE2 · UNKNOWN · sponsor: **HealthCare Global Enterprise Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Tongue Neoplasms
- Squamous Cell Carcinoma
- Anterior Tongue Squamous Cell Carcinoma

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Cisplatin
- **DRUG:** 5FU
- **RADIATION:** Radiotherapy
- **PROCEDURE:** Glossectomy

## Key facts

- **NCT ID:** NCT02985255
- **Lead sponsor:** HealthCare Global Enterprise Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02985255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02985255, "Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02985255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*